losartan has been researched along with sb 202190 in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Berk, BC; Che, ZQ; Gao, PJ; Ji, KD; Shen, WL; Yan, C; Yin, M; Zhu, DL | 1 |
1 other study(ies) available for losartan and sb 202190
Article | Year |
---|---|
NAD(P)H oxidase-derived reactive oxygen species regulate angiotensin-II induced adventitial fibroblast phenotypic differentiation.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Anthracenes; Aorta, Thoracic; Cell Differentiation; Cells, Cultured; Connective Tissue; Fibroblasts; Free Radical Scavengers; Imidazoles; JNK Mitogen-Activated Protein Kinases; Losartan; Male; Membrane Glycoproteins; NADPH Oxidase 2; NADPH Oxidases; Oligodeoxyribonucleotides, Antisense; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Pyridines; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species | 2006 |